Inactive Instrument

All News Qiagen Marseille

Equities

FR0010626028

End-of-day quote Euronext Paris Other stock markets
- ^EUR	-

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Qiagen Marseille : Implementation of the Mandatory Squeeze-out for the Shares of QIAGEN Marseille	26/15/26	GL
Qiagen Marseille : Implementation of the Mandatory Squeeze-out for the Shares of QIAGEN Marseille	26/15/26	PU
Qiagen Marseille : SA : PUBLIC TENDER OFFER ON THE SHARES OF SA \| information memorandum in response	16/15/16	GL
Qiagen Marseille : PUBLIC TENDER OFFER ON THE SHARES OF QIAGEN MARSEILLE SA	16/15/16	GL
Qiagen Marseille : announces that its shareholders in an extraordinary general meeting voted in favor of the completion of the reorganization	17/15/17	GL
Qiagen Marseille : FILING OF A PROPOSED SIMPLIFIED TENDER OFFER TARGETING THE SHARES OF QIAGEN Marseille SA	12/15/12	GL
Qiagen Marseille : Availability of QIAGEN Marseille's draft reply document in response to the tender offer initiated by QIAGEN N.V.	12/15/12	GL
QIAGEN Marseille : accepts the HalioDx offer for acquisition of its assets except IP	19/15/19	PU
QIAGEN MARSEILLE : accepts the HalioDx offer for acquisition of its assets except IP	09/15/09	GL
QIAGEN Marseille : reports half-year 2014 results	11/14/11	PU
QIAGEN Marseille : reports 2014 half-year revenues of 8.3 m€	04/14/04	PU
QIAGEN Marseille : reports full-year 2013 results	27/14/27	PU
QIAGEN MARSEILLE : reports 2013 revenues of 14.8 M€	06/14/06	PU
QIAGEN MARSEILLE : to focus on innovative biomarkers development and Next Generation Sequencing IVD applications	11/14/11	PU
QIAGEN MARSEILLE : QIAGEN announces European launch of therascreen® IDH1/2 test for gliomas as well as a IDH1/2-related collaboration with Mayo Clinic	06/14/06	PU
QIAGEN MARSEILLE : reports 2013 half-year revenues of 7.6 m€	07/13/07	PU
QIAGEN MARSEILLE : reports FY 2012 revenues of 13.2 M€	09/13/09	PU
IPSOGEN : Filing of a draft reply document established by IPSOGEN in response to a draft tender offer initiated by QIAGEN N.V.	18/11/18	PU
IPSOGEN : receives an offer from QIAGEN to fully acquire IPSOGEN and enters into exclusive negotiations	15/11/15	PU
IPSOGEN : to present two studies on the Genomic Grade at ASCO 2011 in Chicago, Ill, USA	30/11/30	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Qiagen Marseille

Equities

FR0010626028

All News

Filters